Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Seltsam

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Biomed Research International|December 19, 2013
MHC universal cells survive in an allogeneic environment after incompatible transplantationConstança Figueiredo, Dirk Wedekind, Thomas Müller, et al.
Transfusion|May 8, 2018
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectivelyMarkus Eickmann, Ute Gravemann, Wiebke Handke, et al.
Immunogenetics|May 1, 2004
A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligandsChristina Bade-Doeding, Holger-Andreas Elsner, Britta Eiz-Vesper, et al.
Transfusion|December 29, 2017
Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentratesSinyoung Kim, Wiebke Handke, Ute Gravemann, et al.
Immunogenetics|December 14, 2004
Peptide-binding motif of HLA-A*6603Christina Bade-Doeding, Britta Eiz-Vesper, Constanca Figueiredo, et al.
Transfusion|August 20, 2014
Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet productsPetra Pohler, Meike Müller, Carla Winkler, et al.
Transfusion|August 22, 2012
Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood productsEike Steinmann, Ute Gravemann, Martina Friesland, et al.
Transfusion|September 10, 2022
New ultraviolet C light-based method for pathogen inactivation of red blood cell unitsWiebke Handke, Ute Gravemann, Thomas H Müller, et al.
Vox Sanguinis|January 14, 2020
Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible lightMarkus Eickmann, Ute Gravemann, Wiebke Handke, et al.
Transfusion|September 4, 2007
Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO geneAxel Seltsam, Franz F Wagner, Daniela Grüger, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Biomed Research International|December 19, 2013
MHC universal cells survive in an allogeneic environment after incompatible transplantationConstança Figueiredo, Dirk Wedekind, Thomas Müller, et al.
Transfusion|May 8, 2018
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectivelyMarkus Eickmann, Ute Gravemann, Wiebke Handke, et al.
Immunogenetics|May 1, 2004
A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligandsChristina Bade-Doeding, Holger-Andreas Elsner, Britta Eiz-Vesper, et al.
Transfusion|December 29, 2017
Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentratesSinyoung Kim, Wiebke Handke, Ute Gravemann, et al.
Immunogenetics|December 14, 2004
Peptide-binding motif of HLA-A*6603Christina Bade-Doeding, Britta Eiz-Vesper, Constanca Figueiredo, et al.
Transfusion|August 20, 2014
Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet productsPetra Pohler, Meike Müller, Carla Winkler, et al.
Transfusion|August 22, 2012
Two pathogen reduction technologies--methylene blue plus light and shortwave ultraviolet light--effectively inactivate hepatitis C virus in blood productsEike Steinmann, Ute Gravemann, Martina Friesland, et al.
Transfusion|September 10, 2022
New ultraviolet C light-based method for pathogen inactivation of red blood cell unitsWiebke Handke, Ute Gravemann, Thomas H Müller, et al.
Vox Sanguinis|January 14, 2020
Inactivation of three emerging viruses - severe acute respiratory syndrome coronavirus, Crimean-Congo haemorrhagic fever virus and Nipah virus - in platelet concentrates by ultraviolet C light and in plasma by methylene blue plus visible lightMarkus Eickmann, Ute Gravemann, Wiebke Handke, et al.
Transfusion|September 4, 2007
Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO geneAxel Seltsam, Franz F Wagner, Daniela Grüger, et al.
Pageof 8